About Shulov Innovative Science
Shulov Innovative Science is a company based in Rehovot (Israel) founded in 1985 by Aviv Marx and Aharon Shulov. It operates as a B2B. Shulov Innovative Science offers products and services including ZEP-3 and ZEP-4. Shulov Innovative Science operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Nimbus Therapeutics, Escient Pharmaceuticals and Aclaris Therapeutics, among others.
- Headquarter Rehovot, Israel
- Founders Aviv Marx, Aharon Shulov
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Shulov Innovative Science Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Shulov Innovative Science
Shulov Innovative Science offers a comprehensive portfolio of products and services, including ZEP-3 and ZEP-4. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic peptide for anti-inflammatory and antiviral treatments.
Analgesic peptide for various therapeutic indications.
Funding Insights of Shulov Innovative Science
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Shulov Innovative Science
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shulov Innovative Science
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shulov Innovative Science Comparisons
Competitors of Shulov Innovative Science
Shulov Innovative Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Nimbus Therapeutics, Escient Pharmaceuticals and Aclaris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Shulov Innovative Science
When was Shulov Innovative Science founded?
Shulov Innovative Science was founded in 1985.
Where is Shulov Innovative Science located?
Shulov Innovative Science is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Who is the current CEO of Shulov Innovative Science?
Aviv Marx is the current CEO of Shulov Innovative Science. They have also founded this company.
What does Shulov Innovative Science do?
Shulov Innovative Science Ltd (SIS) is a biopharmaceutical company that develops new chemical entities, such as ZEP-3 and ZEP-4 peptides, for therapeutic applications including anti-inflammatory and antiviral agents. They conduct clinical studies, including Phase I and II trials for conditions like Herpes Labialis and Atopic Dermatitis. Based in Rehovot, Israel, SIS focuses on safe, non-steroid treatments through topical and other formulations, targeting various indications without steroids for a competitive edge.
Who are the top competitors of Shulov Innovative Science?
Shulov Innovative Science's top competitors include Moderna, Adaptive Biotechnologies and Escient Pharmaceuticals.
What products or services does Shulov Innovative Science offer?
Shulov Innovative Science offers ZEP-3 and ZEP-4.